LINC00942 accelerates esophageal cancer progression via NAT10/HSPD1

Key Points

• LINC00942 promotes esophageal cancer progression, leading to increased tumor growth.
• Key evidence shows that high linc00942 levels correlate with rapid advancement of tumor stages.
• Analysis focused on the interaction between NAT10 and HSPD1 in cancer cells.
• Findings highlight the necessity for targeted therapies that address linc00942's role in cancer progression.